GlassScriptPhysician profile
Bryan C Fagan
NPI 1669683405
$7,742.99
in general payments reported to CMS, 2019-2025
14 companies · $897 in 2025
The $897 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,545 · 2020: $589 · 2021: $62.64 · 2022: $1,284 · 2023: $238 · 2024: $127 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $632 · Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $632.08 |
| Food and Beverage | $630.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $4,813.25 | 2019-2023 | |
| Arthrex, INC. | $2,093.58 | 2019-2025 | |
| Cumberland Pharmaceuticals, INC. | $362.09 | 2019-2025 | Vibativ, Caldolor |
| Inspire Medical Systems, INC. | $137.05 | 2024-2025 | Inspire |
| Zimmer Biomet Holdings, INC. | $130.31 | 2023 | Gel-One Cross-Linked Hyaluronate, Persona, Comprehensive Shoulder System |
| Convatec INC. | $49.32 | 2023-2025 | |
| Baudax Bio INC. | $30.95 | 2020 | |
| Globus Medical, INC. | $25.41 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $19.72 | 2025 | Zilretta |
| Bioventus LLC | $18.06 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.71 | 2022 | |
| Endo Pharmaceuticals INC. | $16.93 | 2024 | Xiaflex |
| Axogen | $14.48 | 2019 | |
| International Rehabilitative Sciences, INC | $14.13 | 2025 | Rs-4i Plus With Intersperse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Fagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.